Volume : 11, Issue : 01, January – 2024

Title:

FORMULATION AND CHARACTERIZATION OF FLURBIPROFEN LIPOSOMES

Authors :

Amtul aziz madiha shazmeen, K.Yadava Reddy

Abstract :

Flurbiprofen liposomes were prepared by thin film hydration technique and the phospolipid concentrations were optimized by various trials In the present study liposomes containing Flurbiprofen was prepared. The effect of increase in phospolipid concentration in various parameters like particle size and invitro release profile were studied. The Flurbiprofen liposomes were formulated and evaluated for its drug content,entrapment efficiency, particle size analysis,zeta potential and invitro drug release profile. Based on the results of Flurbiprofen liposomes formulations (FLF 1- FLF 5) formulation FLF4 was selected as the best formulation in which the particle size was 271.1nm and the entrapment was 85.72%. The in vitro % drug release of FLF4 formulation was 99.47± 0.72% at 24 hrs and it was found to be suitable formulation to manage the condition of rheumatoid arthritis. Hence it can be concluded that the newly formulated controlled release liposomal drug delivery systems of Flurbiprofen may be ideal and effective in the management of pain due to arthritis by allowing the drug to release continuously for 24 hrs.
Key words: Formulation, Characterizations, Flurbiprofen, Liposomes

Cite This Article:

Please cite this article in press Amtul aziz madiha shazmeen et al., Formulation And Characterization Of Flurbiprofen Liposomes, Indo Am. J. P. Sci, 2024; 11 (01).

Number of Downloads : 10

References:

1. Abolfazl A, Rogaie RS, Soodabeh D, Sang WJ, Nosratollah Z, Younes H, et al. Liposome: Classification, preparation, and applications. Nanoscale Res Lett 2013;8:102.
2. Agnieszka EW, Emilian A. Interfacial properties of phosphatidylcholinebased dispersed systems. Ind Eng Chem Res 2015;54:6489-96.
3. Zhenjun H, Xuan L, Ting Z, Yanzhi S, Zhennan S, Jing L, et al. Progress involving new techniques for liposome preparation. Asian J Pharm Sci 2014;9:176-82.
4. Maximiliano G, Claudia S, Carlos B, Adriana MC. Percutaneous drug delivery systems for improving antifungal therapy effectiveness: A review. Int J Pharm Pharm Sci 2014;6:8-16.
5. Loveleenpreet K, Prabhjot K, Khan MU. Liposome as a drug carrier-A review. Int J Res Pharm Chem 2013;3:121-8.
6. Kamra M, Diwan A. Liposomes in dermatological diseases. J Appl Pharm Res 2017;5:1-8.
7. Bhupendra P, Narendra K, Suman S, Amit R. Liposome: Method of preparation, advantages, evaluation and its application. J Appl Pharm Res 2015;3:1-8.
8. Gyati S, Davinder S, Abhay A. Novel vesicular carriers for topical drug delivery and their applications. Int J Pharm Sci Rev Res 2013;21:77-86.
9. Marilene E, Maria HA, Jaime C, José MS. Evolution of liposomal carriers intended to anticancer drug delivery: An overview. Int J Curr Pharm Res 2015;7:26-33.
10. Prasanthi D, Lakshmi PK. Vesicles-mechanism of transdermal permeation: A Review. Asian J Pharm Clin Res 2012;5:18-25.
11. Sudipta D, Arnab S, Ananya B. Design, development and evaluation of fluconazole topical gel. Asian J Pharm Clin Res 2015;8:132-5.
12. Gagan G, Tarun G, Basant M, Gaurav C, Goutam R, Amit KG. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv 2016;22:1027-42.
13. Susanta P, Mayukh J, Anannya B, Sunirmal B, Joyeeta GR, Puja C. Topical liposomal gel: A new strategy of novel drug delivery. World J Pharm Pharm Sci 2016;6:568-77.